Helius Medical Technologies Announces Additional Authorized Claim For Payment For PoNS Device From CignaHealth

- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161-

-This follows another recent authorization by Anthem Multiplan for PoNS Device at out-of-network negotiated price of $19,160-

NEWTOWN, Pa., June 16, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced an additional authorized claim for payment for the PoNS Device from CignaHealth. CignaHealth becomes the fifth major payer to authorize claims for payment for the PoNS Device following the recent authorization by Anthem MultiPlan.

Depending on the individual's deductible and out-of-pocket costs, these claims may not result in an immediate PoNS Device sale.